Neon Therapeutics Presents Updated Data At The Society For Immunotherapy Of Cancers 33rd Annual Meeting | Latest News RSS feed

Neon Therapeutics Presents Updated Data At The Society For Immunotherapy Of Cancers 33rd Annual Meeting - Latest News


Neon Therapeutics Presents Updated Data at the Society for Immunotherapy of Cancer’s 33rd Annual Meeting

Nov. 09, 2018 (GLOBE NEWSWIRE) -- Neon Therapeutics ... and new data relating to its NEO-PTC-01 program at the Society for Immunotherapy of Cancer’s (SITC) 33 rd Annual Meeting in ... read more

Neon Therapeutics to Present Data from Ongoing Phase 1b NT-001 Clinical Trial at the European Society for Medical Oncology 2018 Congress

Oct. 03, 2018 (GLOBE NEWSWIRE) -- Neon ... therapeutics, today announced that updated data from NT-001, its ongoing Phase 1b clinical trial evaluating NEO-PV-01 in the metastatic setting, will be pres... read more

Neon Therapeutics Is An Emerging Player In Personalized Immunotherapy With Catalysts Ahead

In the case of Neon, we have a data update for its NT-001 ... Neon will present potentially a broader set of results on NEO-PV-01 at the Society of Immunotherapy of Cancer (SITC) Annual Meeting taking ... read more

Looking for another news?


Celldex Presents Emerging MerTK Antibody Program at the Society for Immunotherapy of Cancer’s 33rd Annual Meeting

Celldex Presents Emerging MerTK Antibody Program at the Society for Immunotherapy of Cancer's 33rd Annual Meeting Antibody technology ... 2018 (GLOBE NEWSWIRE) -- Celldex Therapeutics, Inc. (NASDAQ:CL... read more


Neon Therapeutics, Inc. (NTGN)

Nov. 09, 2018 (GLOBE NEWSWIRE) -- Neon Therapeutics, Inc. (NTGN), a clinical-stage immuno-oncology company developing neoantigen-based therapeutics, today presents updated data ... Society for Immunot... read more

Personalis, Inc. to Present New Data at the Society for Immunotherapy of Cancer’s (SITC) 33RD Annual Meeting

will present new data at the upcoming Society for Immunotherapy of Cancer’s (SITC) 33rd Annual Meeting, taking place in Washington, D.C., November 9-11, 2018. Following is a list of abstracts that wil... read more

Alligator Bioscience and Aptevo Therapeutics...

APVO), a biotechnology company focused on developing novel immuno-oncology and hematology therapeutics, today announced that new preclinical data for ALG.APV-527 are being presented at the Society for ... read more

Neon Therapeutics Presents Updated Data at the Society for Immunotherapy of Cancer's 33rd Annual Meeting

Nov. 09, 2018 (GLOBE NEWSWIRE) -- Neon Therapeutics, Inc. (Nasdaq: NTGN), a clinical-stage immuno-oncology company developing neoantigen-based therapeutics, today presents updated data ... Society for ... read more

Neon Therapeutics Presents Updated Data at the Society for Immunotherapy of Cancer’s 33rd Annual Meeting

Nov. 09, 2018 (GLOBE NEWSWIRE) -- Neon Therapeutics, Inc. (Nasdaq: NTGN), a clinical-stage immuno-oncology company developing neoantigen-based therapeutics, today presents updated data ... Society for ... read more



FeedsRSS Created by. Full RSS Feed | Privacy Policy | Contact Us